Search Results
Nov 24, 2025, 11:00 ET Search Funds y Fusiones Estratégicas: Cómo las PyMEs están acelerando su expansión en América Latina
https://mma.prnewswire.com/media/2827949/Caio_Nascimbeni__CEO_da_Syonet__Cr_dito_da_imagem_Luciano_Alves__1.jpg
More news about: Syonet
Nov 24, 2025, 02:11 ET Pin Therapeutics Initiates First-Patient Dosing of CK1α Degrader PIN-5018 in Phase 1 Trial
disease with no approved standard-of-care therapy. In two patient-derived xenograft (PDX) models, treatment with PIN-5018 resulted in a complete response (CR) in one model and marked tumor regression in the other, demonstrating robust antitumor activity and supporting clinical translation.Expansion
More news about: Pin Therapeutics
Nov 23, 2025, 01:21 ET Midea zeigt auf der C&R 2025 in Madrid ein umfassendes Angebot an nachhaltigen HLK-Systemen
content:https://www.prnewswire.com/news-releases/midea-zeigt-auf-der-cr-2025-in-madrid-ein-umfassendes-angebot-an-nachhaltigen-hlk-systemen-302623951.html
More news about: Midea RAC Division
Nov 23, 2025, 01:16 ET Společnost Midea představila na veletrhu C&R 2025 v Madridu komplexní řadu udržitelných produktů HVAC
content:https://www.prnewswire.com/news-releases/spolenost-midea-pedstavila-na-veletrhu-cr-2025-v-madridu-komplexni-adu-udritelnych-produkt-hvac-302623950.html
More news about: Midea RAC Division
Nov 23, 2025, 01:13 ET Midea demonstreert uitgebreide duurzame HVAC-lijn tijdens C&R 2025 in Madrid
content:https://www.prnewswire.com/nl/persberichten/midea-demonstreert-uitgebreide-duurzame-hvac-lijn-tijdens-cr-2025-in-madrid-302623949.html
More news about: Midea RAC Division
Nov 22, 2025, 13:47 ET Midea Building Technologies představuje na C&R 2025 v Madridu žhavé novinky ve vytápění, ventilaci a klimatizaci
content:https://www.prnewswire.com/news-releases/midea-building-technologies-pedstavuje-na-cr-2025-v-madridu-have-novinky-ve-vytapni-ventilaci-a-klimatizaci-302623910.html
More news about: Midea Building Technologies
Nov 22, 2025, 13:42 ET Midea Building Technologies демонстрирует передовые решения в области ОВКВ на выставке C&R 2025 в Мадриде
View original content:https://www.prnewswire.com/news-releases/midea-building-technologies---------cr-2025---302623909.html
More news about: Midea Building Technologies
Nov 21, 2025, 14:54 ET Midea Building Technologies präsentiert hochmoderne HLK-Lösungen auf der C&R 2025 in Madrid
content:https://www.prnewswire.com/news-releases/midea-building-technologies-prasentiert-hochmoderne-hlk-losungen-auf-der-cr-2025-in-madrid-302623567.html
More news about: Midea Building Technologies
Nov 21, 2025, 14:36 ET Midea Building Technologies présente des solutions CVC de pointe au salon C&R 2025 à Madrid
content:https://www.prnewswire.com/news-releases/midea-building-technologies-presente-des-solutions-cvc-de-pointe-au-salon-cr-2025-a-madrid-302623548.html
More news about: Midea Building Technologies
Nov 21, 2025, 13:56 ET Midea presenta al C&R 2025 di Madrid la sua gamma completa di sistemi HVAC sostenibili
content:https://www.prnewswire.com/news-releases/midea-presenta-al-cr-2025-di-madrid-la-sua-gamma-completa-di-sistemi-hvac-sostenibili-302623515.html
More news about: Midea RAC Division
Nov 21, 2025, 13:16 ET Midea expose sa série complète de systèmes de chauffage, de ventilation et de climatisation durables au salon C&R 2025 à Madrid
content:https://www.prnewswire.com/news-releases/midea-expose-sa-serie-complete-de-systemes-de-chauffage-de-ventilation-et-de-climatisation-durables-au-salon-cr-2025-a-madrid-302623478.html
More news about: Midea RAC Division
Nov 21, 2025, 13:13 ET Midea predstavuje na veľtrhu C&R 2025 v Madride komplexný sortiment udržateľných systémov HVAC
content:https://www.prnewswire.com/news-releases/midea-predstavuje-na-vetrhu-cr-2025-v-madride-komplexny-sortiment-udratenych-systemov-hvac-302623476.html
More news about: Midea RAC Division
Nov 21, 2025, 13:08 ET Midea presenta su completa gama de sistemas HVAC sostenibles en C&R 2025 en Madrid
content:https://www.prnewswire.com/news-releases/midea-presenta-su-completa-gama-de-sistemas-hvac-sostenibles-en-cr-2025-en-madrid-302623470.html
More news about: Midea RAC Division
Nov 21, 2025, 13:04 ET Midea prezentuje kompleksową ofertę zrównoważonych produktów i systemów HVAC na targach C&R 2025 w Madrycie
content:https://www.prnewswire.com/news-releases/midea-prezentuje-kompleksow-ofert-zrownowaonych-produktow-i-systemow-hvac-na-targach-cr-2025-w-madrycie-302623465.html
More news about: Midea RAC Division
Nov 21, 2025, 12:02 ET Midea Building Technologies predstavuje najmodernejšie riešenia HVAC na veľtrhu C&R 2025 v Madride
content:https://www.prnewswire.com/news-releases/midea-building-technologies-predstavuje-najmodernejie-rieenia-hvac-na-vetrhu-cr-2025-v-madride-302623403.html
More news about: Midea Building Technologies
Nov 21, 2025, 11:56 ET Midea Building Technologies presenta soluciones de climatización de vanguardia en C&R 2025 en Madrid
content:https://www.prnewswire.com/news-releases/midea-building-technologies-presenta-soluciones-de-climatizacion-de-vanguardia-en-cr-2025-en-madrid-302623394.html
More news about: Midea Building Technologies
Nov 21, 2025, 11:53 ET Midea Building Technologies prezentuje nowatorskie rozwiązania HVAC na Międzynarodowej Wystawie Klimatyzacji i Chłodnictwa C&R 2025 w Madrycie
content:https://www.prnewswire.com/news-releases/midea-building-technologies-prezentuje-nowatorskie-rozwizania-hvac-na-midzynarodowej-wystawie-klimatyzacji-i-chodnictwa-cr-2025-w-madrycie-302623386.html
More news about: Midea Building Technologies
Nov 21, 2025, 11:23 ET Midea демонстрирует комплексную линейку устойчивых систем ОВКВ на выставке C&R 2025 в Мадриде
View original content:https://www.prnewswire.com/news-releases/midea---------cr-2025---302623360.html
More news about: Midea RAC Division
Nov 21, 2025, 07:37 ET Les données de PMB-CT01 BAFFR-CAR T de PeproMene Bio ont été sélectionnées pour deux présentations orales lors de la 67e réunion annuelle de l'ASH 2025.
cellules effectrices de l'immunité de grade ˃1 (ICANS).Efficacité :Les 7 premiers patients ont tous obtenu une réponse complète (CR) 1 à 3 mois après la perfusion, y compris ceux qui avaient déjà été traités avec une thérapie CAR T CD19 et ceux dont la maladie était CD19-négative.Durabilité :Les
More news about: PeproMene Bio, Inc.
Nov 21, 2025, 05:28 ET Midea Demonstrates Comprehensive Sustainable HVAC Lineup at C&R 2025 in Madrid
content:https://www.prnewswire.co.uk/news-releases/midea-demonstrates-comprehensive-sustainable-hvac-lineup-at-cr-2025-in-madrid-302623078.html
More news about: Midea RAC Division
Nov 21, 2025, 05:03 ET Midea Demonstrates Comprehensive Sustainable HVAC Lineup at C&R 2025 in Madrid
multimedia:https://www.prnewswire.com/news-releases/midea-demonstrates-comprehensive-sustainable-hvac-lineup-at-cr-2025-in-madrid-302623059.htmlSOURCE
More news about: Midea RAC Division
Nov 21, 2025, 01:32 ET Midea Building Technologies Showcases Cutting-Edge HVAC Solutions at C&R 2025 in Madrid
content:https://www.prnewswire.co.uk/news-releases/midea-building-technologies-showcases-cutting-edge-hvac-solutions-at-cr-2025-in-madrid-302622913.html
More news about: Midea Building Technologies
Nov 20, 2025, 16:25 ET Daten zu PMB-CT01 BAFFR-CAR T von PeproMene Bio für zwei mündliche Präsentationen auf der 67. Jahrestagung 2025 von ASH ausgewählt
Wirksamkeit: Alle ersten 7 Patienten erreichten 1-3 Monate nach der Infusion ein komplettes Ansprechen (CR), einschließlich derjenigen, die zuvor mit einer CD19-CAR-T-Therapie behandelt wurden, und derjenigen mit CD19-negativer Erkrankung.
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
(ICANS) Efficacy: All the first 7 patients achieved a Complete Response (CR) at 1–3 months post-infusion, including those previously treated with CD19 CAR T therapy and those with CD19-negative disease.
More news about: PeproMene Bio, Inc.
Nov 20, 2025, 10:12 ET PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting
(ICANS) Efficacy: All the first 7 patients achieved a Complete Response (CR) at 1–3 months post-infusion, including those previously treated with CD19 CAR T therapy and those with CD19-negative disease.
More news about: PeproMene Bio, Inc.